We chat with Lucas Schulz about what pharmacists should be evaluating when it comes to all of the rapidly emerging studies and data surrounding the treatment of COVID-19 patients. Our content matter experts provide recommendations on how to critically assess and potentially apply information to these studies into real practice situations.